RMC No. 93-2024: Updates to VAT-Exempt Medicines Following FDA Letter on TRAIN and CREATE Acts
RMC No. 93-2024 publishes FDA-endorsed updates to the VAT-exempt list of medicines under TRAIN and CREATE Acts, including additions and deletions, effective upon FDA publication. Businesses and tax practitioners handling pharmaceuticals must review the updated VAT-exempt list as endorsed by the Food and Drug Administration (FDA) and published by the Bureau of Internal Revenue. This […]